Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Anti-Obesity Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Anti-Obesity Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Anti-Obesity Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Eisai Company
Rhythm Pharmaceuticals
Vivus
Shionogi USA
Alizyme
Novo Nordisk
Bristol-Myers Squibb
FlaxoSithKline plc
Zafgen
Norgine Pharmaceuticals Ltd
Pfizer
BoehringerIngelheim GmbH
Takeda Pharmaceutical
By Type:
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
By End-User:
Peripherally Acting Anti-obesity Drugs
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-Obesity Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Anti-Obesity Therapeutics Market Size and Growth Rate of Centrally Acting Anti-obesity Drugs from 2016 to 2027
-
1.3.2 China Anti-Obesity Therapeutics Market Size and Growth Rate of Peripherally Acting Anti-obesity Drugs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Anti-Obesity Therapeutics Market Size and Growth Rate of Peripherally Acting Anti-obesity Drugs from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-Obesity Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-Obesity Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Centrally Acting Anti-obesity Drugs
-
3.4.2 Market Size and Growth Rate of Peripherally Acting Anti-obesity Drugs
4 Segmentation of Anti-Obesity Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-Obesity Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-Obesity Therapeutics in Peripherally Acting Anti-obesity Drugs
5 Market Analysis by Regions
-
5.1 China Anti-Obesity Therapeutics Production Analysis by Regions
-
5.2 China Anti-Obesity Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Anti-Obesity Therapeutics Landscape Analysis
-
6.1 North China Anti-Obesity Therapeutics Landscape Analysis by Major Types
-
6.2 North China Anti-Obesity Therapeutics Landscape Analysis by Major End-Users
7 Central China Anti-Obesity Therapeutics Landscape Analysis
-
7.1 Central China Anti-Obesity Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Anti-Obesity Therapeutics Landscape Analysis by Major End-Users
8 South China Anti-Obesity Therapeutics Landscape Analysis
-
8.1 South China Anti-Obesity Therapeutics Landscape Analysis by Major Types
-
8.2 South China Anti-Obesity Therapeutics Landscape Analysis by Major End-Users
9 East China Anti-Obesity Therapeutics Landscape Analysis
-
9.1 East China Anti-Obesity Therapeutics Landscape Analysis by Major Types
-
9.2 East China Anti-Obesity Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Anti-Obesity Therapeutics Landscape Analysis
-
10.1 Northeast China Anti-Obesity Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Anti-Obesity Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Anti-Obesity Therapeutics Landscape Analysis
-
11.1 Southwest China Anti-Obesity Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Anti-Obesity Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Anti-Obesity Therapeutics Landscape Analysis
-
12.1 Northwest China Anti-Obesity Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Anti-Obesity Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Eisai Company
-
13.1.1 Eisai Company Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Rhythm Pharmaceuticals
-
13.2.1 Rhythm Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Vivus
-
13.3.1 Vivus Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Shionogi USA
-
13.4.1 Shionogi USA Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Alizyme
-
13.5.1 Alizyme Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Novo Nordisk
-
13.6.1 Novo Nordisk Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bristol-Myers Squibb
-
13.7.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 FlaxoSithKline plc
-
13.8.1 FlaxoSithKline plc Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Zafgen
-
13.9.1 Zafgen Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Norgine Pharmaceuticals Ltd
-
13.10.1 Norgine Pharmaceuticals Ltd Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Pfizer
-
13.11.1 Pfizer Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 BoehringerIngelheim GmbH
-
13.12.1 BoehringerIngelheim GmbH Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Takeda Pharmaceutical
-
13.13.1 Takeda Pharmaceutical Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Anti-Obesity Therapeutics Market Size and Growth Rate of Centrally Acting Anti-obesity Drugs from 2016 to 2027
-
Figure China Anti-Obesity Therapeutics Market Size and Growth Rate of Peripherally Acting Anti-obesity Drugs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Anti-Obesity Therapeutics Market Size and Growth Rate of Peripherally Acting Anti-obesity Drugs from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Anti-Obesity Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-Obesity Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-Obesity Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-Obesity Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-Obesity Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Centrally Acting Anti-obesity Drugs
-
Figure Market Size and Growth Rate of Peripherally Acting Anti-obesity Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-Obesity Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-Obesity Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Peripherally Acting Anti-obesity Drugs
-
Table China Anti-Obesity Therapeutics Production by Regions
-
Table China Anti-Obesity Therapeutics Production Share by Regions
-
Figure China Anti-Obesity Therapeutics Production Share by Regions in 2016
-
Figure China Anti-Obesity Therapeutics Production Share by Regions in 2021
-
Figure China Anti-Obesity Therapeutics Production Share by Regions in 2027
-
Table China Anti-Obesity Therapeutics Consumption by Regions
-
Table China Anti-Obesity Therapeutics Consumption Share by Regions
-
Figure China Anti-Obesity Therapeutics Consumption Share by Regions in 2016
-
Figure China Anti-Obesity Therapeutics Consumption Share by Regions in 2021
-
Figure China Anti-Obesity Therapeutics Consumption Share by Regions in 2027
-
Table North China Anti-Obesity Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Anti-Obesity Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Anti-Obesity Therapeutics Consumption Share by Types in 2016
-
Figure North China Anti-Obesity Therapeutics Consumption Share by Types in 2021
-
Figure North China Anti-Obesity Therapeutics Consumption Share by Types in 2027
-
Table North China Anti-Obesity Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Anti-Obesity Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Anti-Obesity Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Anti-Obesity Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Anti-Obesity Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Anti-Obesity Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Anti-Obesity Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Anti-Obesity Therapeutics Consumption Share by Types in 2016
-
Figure Central China Anti-Obesity Therapeutics Consumption Share by Types in 2021
-
Figure Central China Anti-Obesity Therapeutics Consumption Share by Types in 2027
-
Table Central China Anti-Obesity Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Anti-Obesity Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Anti-Obesity Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Anti-Obesity Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Anti-Obesity Therapeutics Consumption Share by End-Users in 2027
-
Table South China Anti-Obesity Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Anti-Obesity Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Anti-Obesity Therapeutics Consumption Share by Types in 2016
-
Figure South China Anti-Obesity Therapeutics Consumption Share by Types in 2021
-
Figure South China Anti-Obesity Therapeutics Consumption Share by Types in 2027
-
Table South China Anti-Obesity Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Anti-Obesity Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Anti-Obesity Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Anti-Obesity Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Anti-Obesity Therapeutics Consumption Share by End-Users in 2027
-
Table East China Anti-Obesity Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Anti-Obesity Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Anti-Obesity Therapeutics Consumption Share by Types in 2016
-
Figure East China Anti-Obesity Therapeutics Consumption Share by Types in 2021
-
Figure East China Anti-Obesity Therapeutics Consumption Share by Types in 2027
-
Table East China Anti-Obesity Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Anti-Obesity Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Anti-Obesity Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Anti-Obesity Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Anti-Obesity Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Anti-Obesity Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Anti-Obesity Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Anti-Obesity Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Anti-Obesity Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Anti-Obesity Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Anti-Obesity Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Anti-Obesity Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Anti-Obesity Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Anti-Obesity Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Anti-Obesity Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Anti-Obesity Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Anti-Obesity Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Anti-Obesity Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Anti-Obesity Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Anti-Obesity Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Anti-Obesity Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Anti-Obesity Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Anti-Obesity Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Anti-Obesity Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Anti-Obesity Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Anti-Obesity Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Anti-Obesity Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Anti-Obesity Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Anti-Obesity Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Anti-Obesity Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Anti-Obesity Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Anti-Obesity Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Anti-Obesity Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Anti-Obesity Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Anti-Obesity Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Eisai Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Company
-
Figure Sales and Growth Rate Analysis of Eisai Company
-
Figure Revenue and Market Share Analysis of Eisai Company
-
Table Product and Service Introduction of Eisai Company
-
Table Company Profile and Development Status of Rhythm Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rhythm Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Rhythm Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Rhythm Pharmaceuticals
-
Table Product and Service Introduction of Rhythm Pharmaceuticals
-
Table Company Profile and Development Status of Vivus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus
-
Figure Sales and Growth Rate Analysis of Vivus
-
Figure Revenue and Market Share Analysis of Vivus
-
Table Product and Service Introduction of Vivus
-
Table Company Profile and Development Status of Shionogi USA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi USA
-
Figure Sales and Growth Rate Analysis of Shionogi USA
-
Figure Revenue and Market Share Analysis of Shionogi USA
-
Table Product and Service Introduction of Shionogi USA
-
Table Company Profile and Development Status of Alizyme
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alizyme
-
Figure Sales and Growth Rate Analysis of Alizyme
-
Figure Revenue and Market Share Analysis of Alizyme
-
Table Product and Service Introduction of Alizyme
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of FlaxoSithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of FlaxoSithKline plc
-
Figure Sales and Growth Rate Analysis of FlaxoSithKline plc
-
Figure Revenue and Market Share Analysis of FlaxoSithKline plc
-
Table Product and Service Introduction of FlaxoSithKline plc
-
Table Company Profile and Development Status of Zafgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zafgen
-
Figure Sales and Growth Rate Analysis of Zafgen
-
Figure Revenue and Market Share Analysis of Zafgen
-
Table Product and Service Introduction of Zafgen
-
Table Company Profile and Development Status of Norgine Pharmaceuticals Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Norgine Pharmaceuticals Ltd
-
Figure Sales and Growth Rate Analysis of Norgine Pharmaceuticals Ltd
-
Figure Revenue and Market Share Analysis of Norgine Pharmaceuticals Ltd
-
Table Product and Service Introduction of Norgine Pharmaceuticals Ltd
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of BoehringerIngelheim GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BoehringerIngelheim GmbH
-
Figure Sales and Growth Rate Analysis of BoehringerIngelheim GmbH
-
Figure Revenue and Market Share Analysis of BoehringerIngelheim GmbH
-
Table Product and Service Introduction of BoehringerIngelheim GmbH
-
Table Company Profile and Development Status of Takeda Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
-
Table Product and Service Introduction of Takeda Pharmaceutical
-
